Search
The goals are enhancing patient safety, improving the patient experience and increasing operational efficiencies.
The deal with Pfizer will reduce the price of the company’s prescription drugs for Medicaid to Most Favored Nation pricing.
The president says he will impose the tariffs on non-generic drugs unless manufacturers build plants in America.
Hospitals should start with data when going to payers to request a carve-out in contracts due to tariffs, says Ralph Keiser, CEO of ArcheHealth.
Amneal Pharmaceuticals’ laboratory procedures resulted in visibly contaminated injectable medications, FDA says.
"Providers don't want to see rebate models, period," says Attorney Jeff Davis.
This forecast comes as more employees use GLP-1s for obesity, receive cancer diagnoses and use mental health services.
The company says broad tariffs would raise costs, limit patient access and undermine domestic manufacturing.
The agency is recommending that hospitals, health systems and clinics use the FDA-approved drug when available.
Tariffs and drug pricing reforms are a top priority, overtaking traditional concerns such as workforce challenges and cybersecurity.
